Bär & Karrer advised Swiss vehicle manufacturer Aebi Schmidt on its merger with the U.S. specialty vehicle manufacturer The Shyft Group, advised by Lenz & Staehelin. Niederer Kraft Frey advised UBS Switzerland as
Tags :tim meyer
Kellerhals Carrard advised Partners Group, one of the largest firms in the global private markets industry, on acquiring Empira Group, a real estate investment platform with EUR 14 billion in asset value, advised by Bär &
Bär & Karrer has advised funds advised by Equistone on the sale of Nokite EcoSmart Water Heating Systems (Guangdong), a manufacturer of private-label kitchen fittings, from KWC Group to Franke Asia Sourcing. The team
Valfor advised Polygena, a sponsor and partner for SME companies in the industrial and service sectors, in the acquisition of Kubo Tech, a manufacturer and distributor of high-performance sealing solutions and molded rubber parts, from
Bär & Karrer advised Raben Group and Sieber Transport on their partnership to jointly establish Raben Sieber, a new company that will provide an extensive groupage transport network across Switzerland and Europe. The deal
Bär & Karrer advised UBS on the sale of its 50% stake in Swisscard. On 21 October 2024, the deal was finalized with the announcement that UBS Switzerland and American Express Swiss Holdings agreed to the sale
Aunetic, formerly Blika, a portfolio company of Main Capital and leading provider of governance software, has acquired all shares in LARI digital, a leading software provider that offers a cloud-based platform for legal and regulatory
The renowned global private schools group Cognita, with a community of more than 100 schools across 16 countries, has acquired the Swiss-based FOUR-FOREST Group from their founders. Offering education from nursery to secondary levels at three campuses,
Heizkurier Group, a portfolio company of Nord Holding, has acquired Suter Group, a supplier of mobile pellet heating and dehumidification solutions. With the acquisition, the company is implementing its growth and sustainability-focused strategy for Heizkurier
Novartis has completed the spin-off of Sandoz‘s generics and biosimilars business, with the result that Sandoz Group debuted as an independent, publicly traded company. Sandoz shares were successfully listed on the Swiss stock exchange,
